1. Home
  2. CARG vs TARS Comparison

CARG vs TARS Comparison

Compare CARG & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$36.88

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$70.02

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARG
TARS
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CARG
TARS
Price
$36.88
$70.02
Analyst Decision
Buy
Buy
Analyst Count
11
6
Target Price
$38.32
$89.00
AVG Volume (30 Days)
1.0M
916.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
48.21
EPS
0.87
N/A
Revenue
$316,861,000.00
$451,360,000.00
Revenue This Year
$13.89
$56.43
Revenue Next Year
$8.91
$30.19
P/E Ratio
$41.59
N/A
Revenue Growth
59.92
146.71
52 Week Low
$26.39
$48.20
52 Week High
$41.22
$85.25

Technical Indicators

Market Signals
Indicator
CARG
TARS
Relative Strength Index (RSI) 55.14 65.68
Support Level $32.78 $60.95
Resistance Level $38.93 $73.45
Average True Range (ATR) 1.55 3.20
MACD -0.06 1.23
Stochastic Oscillator 44.39 87.12

Price Performance

Historical Comparison
CARG
TARS

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. It provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: